Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effect of TRO19622 on peripheral neuropathy scores
after 6 weeks treatment and is based on the separate assessment of pain and dysesthesia
scores.